X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DISHMAN PHARMA TTK HEALTHCARE/
DISHMAN PHARMA
 
P/E (TTM) x 18.4 25.1 73.4% View Chart
P/BV x 2.2 3.3 64.8% View Chart
Dividend Yield % 0.8 0.7 115.8%  

Financials

 TTK HEALTHCARE   DISHMAN PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
DISHMAN PHARMA
Mar-16
TTK HEALTHCARE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,458374 389.3%   
Low Rs795129 616.8%   
Sales per share (Unadj.) Rs408.7197.8 206.6%  
Earnings per share (Unadj.) Rs12.921.2 60.6%  
Cash flow per share (Unadj.) Rs23.634.7 68.1%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.40.8 55.9%  
Book value per share (Unadj.) Rs164.9179.9 91.7%  
Shares outstanding (eoy) m14.1380.69 17.5%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.81.3 216.6%   
Avg P/E ratio x87.611.9 738.1%  
P/CF ratio (eoy) x47.67.2 657.3%  
Price / Book Value ratio x6.81.4 488.4%  
Dividend payout %38.99.4 412.3%   
Avg Mkt Cap Rs m15,91620,306 78.4%   
No. of employees `0002.20.8 270.7%   
Total wages/salary Rs m1,0905,355 20.4%   
Avg. sales/employee Rs Th2,573.819,252.7 13.4%   
Avg. wages/employee Rs Th485.76,459.5 7.5%   
Avg. net profit/employee Rs Th81.02,064.1 3.9%   
INCOME DATA
Net Sales Rs m5,77615,961 36.2%  
Other income Rs m76265 28.5%   
Total revenues Rs m5,85116,226 36.1%   
Gross profit Rs m4264,103 10.4%  
Depreciation Rs m1521,091 14.0%   
Interest Rs m47944 5.0%   
Profit before tax Rs m3022,334 12.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m120624 19.2%   
Profit after tax Rs m1821,711 10.6%  
Gross profit margin %7.425.7 28.7%  
Effective tax rate %39.726.7 148.7%   
Net profit margin %3.110.7 29.3%  
BALANCE SHEET DATA
Current assets Rs m2,55611,018 23.2%   
Current liabilities Rs m1,6759,517 17.6%   
Net working cap to sales %15.39.4 162.2%  
Current ratio x1.51.2 131.8%  
Inventory Days Days33110 30.3%  
Debtors Days Days3535 100.4%  
Net fixed assets Rs m1,10316,304 6.8%   
Share capital Rs m141161 87.5%   
"Free" reserves Rs m2,18812,907 17.0%   
Net worth Rs m2,33014,516 16.0%   
Long term debt Rs m74,189 0.2%   
Total assets Rs m4,07329,805 13.7%  
Interest coverage x7.43.5 212.5%   
Debt to equity ratio x00.3 1.0%  
Sales to assets ratio x1.40.5 264.8%   
Return on assets %5.68.9 63.1%  
Return on equity %7.811.8 66.2%  
Return on capital %14.917.5 85.2%  
Exports to sales %3.024.8 12.0%   
Imports to sales %0.63.7 16.1%   
Exports (fob) Rs m1723,956 4.3%   
Imports (cif) Rs m35596 5.8%   
Fx inflow Rs m1724,952 3.5%   
Fx outflow Rs m55697 7.9%   
Net fx Rs m1174,255 2.7%   
CASH FLOW
From Operations Rs m2532,786 9.1%  
From Investments Rs m-226-1,529 14.8%  
From Financial Activity Rs m-72-941 7.7%  
Net Cashflow Rs m-41316 -13.0%  

Share Holding

Indian Promoters % 65.4 61.4 106.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 3.7 100.0%  
FIIs % 5.2 12.7 40.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 22.1 116.7%  
Shareholders   12,723 46,261 27.5%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   WOCKHARDT  FULFORD INDIA  MERCK  BIOCON   UNICHEM LAB  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 23, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS